This supports earlier studies showing that TNF-α inhibition in psoriasis is associated with a substantial Th17 cell-count reduction in the patients’ peripheral blood and that this decrease is significantly associated with an adequate response to biologic therapy [53]. The gene discussed is TNF; the disease is psoriasis.